# ANI Pharmaceuticals, Inc. (ANIP)

> ANI Pharmaceuticals, Inc. (ANIP) trades at $68.55 (-0.84%) as of 7:39:32 PM EST on Nov 20, 2026, -7.05% over the past month. Market cap is $1.56B, with 11.9 days to cover in short interest.

Canonical: https://massive.com/quote/anip
Data as of: 2026-11-21T00:39:32.378Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$68.55** -0.58 (-0.84%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$68.90** +0.35 (+0.51%)
As of 7:39:32 PM EST on Nov 20, 2026 · After hours

## Stock performance

How ANI Pharmaceuticals, Inc. (ANIP) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.84% |
| 1W | -4.05% |
| 1M | -7.05% |
| YTD | -13.16% |
| 1Y | -15.35% |
| 52-wk range | $67.14 – $87.76 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for ANIP: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $68.28 – $70.20 |
| Open | $68.96 |
| Prev close | $69.13 |
| Volume | 227.26K |
| Market cap | $1.56B |
| Shares out | 22.72M |

## Valuation and profitability ratios

Valuation and profitability ratios for ANI Pharmaceuticals, Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 14.36 |
| P/S | 1.50 |
| P/B | 2.45 |
| P/FCF | 7.59 |
| ROE | 17.0% |
| ROA | 6.9% |
| Debt/Equity | 0.95 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[ANI Pharmaceuticals, Inc. (ANIP) insider trading](https://massive.com/quote/anip/insider-trading.md): open-market Form 4 buys and sells by ANI Pharmaceuticals, Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events ANI Pharmaceuticals, Inc. has disclosed to the SEC on Form 8-K.

- Nov 16, 2026 · Investor presentation
  “On November 16, 2026, the Company published an updated investor presentation to the investor relations section of its website. The Company may use the updated investor presentation in various meetings with investors and analysts from time to time.”
- Nov 5, 2026 · Tender offer
  “In the Offer, the Company is offering SEK 11.25 in cash for each share of Egetis, SEK 65,750,817 in cash for the EUR 3 million principal amount of the Convertible and SEK 6.99 in cash per Warrant (representing a total value of approximately SEK 5.6 billion or approximately $559.9 million...).”
- Nov 5, 2026 · Investor presentation
  “On November 5, 2026, the Company provided a presentation in connection with a conference call and webcast that will be held on November 5, 2026 with analysts and investors regarding its third quarter 2026 results and the proposed Egetis Therapeutics acquisition.”
- Aug 24, 2026 · Director appointment
  “On August 19, 2026, the Board of Directors (the "Board") of ANI Pharmaceuticals, Inc. (the "Company") appointed Henry Gosebruch to serve on the Board as a director with a term expiring at the Company's 2027 annual meeting of stockholders. Mr. Gosebruch, 53, has served as Chief Executive Officer and a member of the board of directors of Lakefront Biotherapeutics NV... Prior to Lakefront, Mr. Gosebruch served as President and Chief Executive Officer of Neumora Therapeutics, Inc.”
- Aug 7, 2026 · Investor presentation
  “On August 7, 2026, the Company published an updated investor presentation to the investor relations section of its website. The Company may use the updated investor presentation in various meetings with investors and analysts from time to time.”

## Dividend history and stock splits

ANI Pharmaceuticals, Inc.'s recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-6 · Jun 4, 2012

## Similar companies

Public companies in a similar business to ANI Pharmaceuticals, Inc..

- [ADMA](https://massive.com/quote/adma.md) ADMA Biologics, Inc. (-1.27%)
- [ANVS](https://massive.com/quote/anvs.md) Annovis Bio, Inc. (-4.96%)

Daily change in the latest session, 15-minute delayed.

## ANIP short interest

How heavily ANIP is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 11.9 |
| Short interest | 3.58M |
| Avg volume | 301.72K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## ANIP news

The latest news and headlines about ANI Pharmaceuticals, Inc. (ANIP).

- [Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion](https://www.globenewswire.com/news-release/2026/11/06/3397292/0/en/global-health-congress-2026-draws-625-leaders-from-25-countries-to-new-york-names-venture-forum-winners-and-announces-national-and-international-expansion.html) · GlobeNewswire Inc. · Nov 5, 2026 · neutral sentiment
- [Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?](https://www.zacks.com/stock/news/3006274/will-ani-anip-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-fundamental_analysis|yseop_template_7-3006274) · Zacks Investment Research · Oct 13, 2026 · positive sentiment
- [These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar](https://www.zacks.com/stock/news/3005798/these-2-medical-stocks-could-beat-earnings-why-they-should-be-on-your-radar?cid=CS-ZC-FT-fundamental_analysis|zacks_education_earnings_esp-3005798) · Zacks Investment Research · Oct 13, 2026 · positive sentiment
- [How to Find Strong Medical Stocks Slated for Positive Earnings Surprises](https://www.zacks.com/stock/news/3000764/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises?cid=CS-ZC-FT-fundamental_analysis|zacks_education_earnings_esp-3000764) · Zacks Investment Research · Oct 6, 2026 · positive sentiment
- [ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET](https://www.globenewswire.com/news-release/2026/07/24/3332769/0/en/ANI-Pharmaceuticals-to-Discuss-Second-Quarter-2026-Financial-Results-on-August-7-2026-at-8-00-a-m-ET.html) · GlobeNewswire Inc. · Jul 24, 2026 · positive sentiment

## About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 970 |
| Listed | Sep 13, 1999 |

[Company website](https://www.anipharmaceuticals.com)

## FAQ

### What is the ANI Pharmaceuticals, Inc. (ANIP) stock price today?

ANI Pharmaceuticals, Inc. (ANIP) is trading at $68.55 (-0.84% on the day) as of 7:39:32 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is ANI Pharmaceuticals, Inc.?

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology,…

### What is the short interest in ANIP?

As of Oct 30, 2026, ANIP has 3.58M shares short and 11.9 days to cover.

### What exchange is ANIP listed on?

ANI Pharmaceuticals, Inc. (ANIP) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time ANIP quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ANIP`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [ANI Pharmaceuticals, Inc. (ANIP) insider trading](https://massive.com/quote/anip/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
